| 臺大學術典藏 |
2021-10-14T02:45:38Z |
Vitamin D receptor-binding site variants affect prostate cancer progression
|
Lin V.C.; Huang S.-P.; Ting H.-J.; Ma W.-L.; Yu C.-C.; CHAO-YUAN HUANG; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:35Z |
Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer
|
Lin V.C.; Huang S.-P.; CHAO-YUAN HUANG; Yu C.-C.; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:30Z |
A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer
|
Huang E.Y.; Chang Y.-J.; Huang S.-P.; Lin V.C.; Yu C.-C.; CHAO-YUAN HUANG; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:28Z |
Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival
|
CHAO-YUAN HUANG; Hsueh Y.-M.; Chen L.-C.; Cheng W.-C.; Yu C.-C.; Chen W.-J.; Lu T.-L.; Lan K.-J.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:27Z |
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
|
Yu C.-C.; Chen L.-C.; Chiou C.-Y.; Chang Y.-J.; Lin V.C.; CHAO-YUAN HUANG; Lin I.-L.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:26Z |
Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy
|
Yu C.-C.; Chen L.-C.; Lin V.C.; CHAO-YUAN HUANG; Cheng W.-C.; Hsieh A.-R.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:25Z |
Prognostic value of CD1B in localised prostate cancer
|
Lee C.-H.; Chen L.-C.; Yu C.-C.; Lin W.-H.; Lin V.C.; CHAO-YUAN HUANG; Lu T.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:24Z |
Genetic association analysis identifies a role for ANO5 in prostate cancer progression
|
Yu C.-C.; Chen L.-C.; CHAO-YUAN HUANG; Lin V.C.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:23Z |
Genetic analysis reveals a significant contribution of ces1 to prostate cancer progression in taiwanese men
|
Ke C.-C.; Chen L.-C.; Yu C.-C.; Cheng W.-C.; CHAO-YUAN HUANG; Lin V.C.; Lu T.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:22Z |
Genetic analysis identifies the role of HLF in renal cell carcinoma
|
CHAO-YUAN HUANG; HUANG S.-P.; HSUEH Y.-M.; CHEN L.-C.; LU T.-L.; BAO B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:19Z |
NRG1 genetic variant influences the efficacy of androgen-deprivation therapy in men with prostate cancer
|
Huang S.-P.; Chen Y.-T.; Chen L.-C.; Lee C.-H.; CHAO-YUAN HUANG; Yu C.-C.; Lin V.C.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:17Z |
Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes
|
Tsai Y.-C.; CHAO-YUAN HUANG; Hsueh Y.-M.; Fan Y.-C.; Fong Y.-C.; Huang S.-P.; Geng J.-H.; Chen L.-C.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-05-18T08:20:14Z |
Genetic association analysis of cell cycle regulators reveals YWHAZ has prognostic significance in prostate cancer
|
Yu C.-C.; Chen L.-C.; Lin W.-H.; Lin V.C.; CHAO-YUAN HUANG; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-03-04T07:51:16Z |
Phytochemical investigation of Tradescantia albiflora and anti-inflammatory butenolide derivatives
|
Tu, P.-C.;Tseng, H.-C.;Liang, Y.-C.;Huang, G.-J.;Lu, T.-L.;Kuo, T.-F.;Kuo, Y.-H.; Tu, P.-C.; Tseng, H.-C.; Liang, Y.-C.; Huang, G.-J.; Lu, T.-L.; Kuo, T.-F.; Kuo, Y.-H.; TZONG-FU KUO |
| 臺大學術典藏 |
2021-02-02T02:48:06Z |
Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells
|
Wang Y.-M.; Lu T.-L.; PING-NING HSU; Tang C.-H.; Chen J.-H.; Liu K.-C.; Kao J.-T.; Tzen J.T.C.; Wu Y.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:41Z |
Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy
|
Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. |
| 臺大學術典藏 |
2021-02-02T00:46:37Z |
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
|
Huang C.-N.; Huang S.-P.; Pao J.-B.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; YEONG-SHIAU PU; Hsieh C.-J.; Bao B.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:37Z |
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
|
Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Chen L.-M.; Ting W.-C.; Hsieh C.-J.; Huang S.-P. |
| 國立成功大學 |
2021 |
Mst3 involvement in na+ and k+ homeostasis with increasing dietary potassium intake
|
Chan, Chan C.-H.;Wu, S.-N.;Bao, Bao B.-Y.;Li, H.-W.;Lu, T.-L. |
| 國立成功大學 |
2020 |
High efficacy by GAL-021: A known intravenous peripheral chemoreceptor modulator that suppresses BKca-channel activity and inhibits Ik(m) or Ih
|
Lu, T.-L.;Gao, Z.-H.;Li, S.-W.;Wu, S.-N. |
| 國立成功大學 |
2020 |
Effectiveness in block by dexmedetomidine of hyperpolarization-activated cation current, independent of its agonistic effect on α2-adrenergic receptors
|
Lu, T.-L.;Lu, T.-J.;Wu, S.-N. |
| 國立成功大學 |
2019 |
MST3 is involved in ENaC-mediated hypertension
|
Lu, T.-J.;Kan, W.-C.;Yang, S.-S.;Jiang, S.-T.;Wu, S.-N.;Ling, P.;Bao, Bao B.-Y.;Lin, C.-Y.;Yang, Z.-Y.;Weng, Y.-P.;Chan, Chan C.-H.;Lu, T.L. |
| 國立成功大學 |
2019 |
Evidence for effective multiple K+current inhibitions by Tolvaptan, a non-peptide antagonist of vasopressin V2 receptor
|
Lu, T.-L.;Chang, W.-T.;Chan, Chan C.-H.;Wu, S.-N. |
| 臺大學術典藏 |
2018-09-10T18:07:38Z |
A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer
|
Huang, E.Y.;Chang, Y.-J.;Huang, S.-P.;Lin, V.C.;Yu, C.-C.;Huang, C.-Y.;Yin, H.-L.;Chang, T.-Y.;Lu, T.-L.;Bao, B.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:03:33Z |
Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer
|
Lin, V.C.;Huang, S.-P.;Huang, C.-Y.;Yu, C.-C.;Yin, H.-L.;Huang, T.-Y.;Lee, C.-H.;Lu, T.-L.;Bao, B.-Y.; CHAO-YUAN HUANG |
